Sen Y. Han
Key Laboratory Of Carcinogenesis And Translational Research
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications
Sutetinib for Patients with Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase IIb Trial.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: June 16, 2026
Vascularized tumor organoids as models for interpreting therapeutic response.
Journal: Vascular pharmacology
Published: May 09, 2026
Impact of a comprehensive healthy lifestyle score on a broad spectrum of cardiometabolic and related diseases and its incremental value for risk prediction based on the UK biobank database.
Journal: Journal of cardiothoracic surgery
Published: March 05, 2026
Risk of Cardiovascular Disease Mortality in Patients With Diagnosed Cancer and Associated Genetic and Proteomic Mechanisms: A UK Biobank-Based Cohort Study.
Journal: Journal of the American Heart Association
Published: December 30, 2025
SMARCA4-deficient thoracic tumors exhibit an immunosuppressive microenvironment and respond to combined antiangiogenic and immune checkpoint inhibitor therapy.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: December 04, 2025
Cumulative Incidence and Type-Specific Risk Factors of Pneumonitis After Definitive Chemoradiotherapy With or Without Immunotherapy in Locally Advanced Non-Small Cell Lung Cancer.
Journal: Clinical lung cancer
Published: July 18, 2025
Treatment Efficacy, Chemoradiotherapy Benefits, and Survival Disparities by Histology in Primary Mediastinal Germ Cell Tumors: 15-Year Results of a Single-Center Cohort Study.
Journal: Asia-Pacific journal of clinical oncology
Published: April 01, 2025
Real-world Study of Icotinib in EGFR Mutant Non-small Cell Lung Cancer Based on the Therapeutic Drug Monitoring
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: February 23, 2025
Real-world analysis of the efficacy and safety of lorlatinib in ALK-positive non-small cell lung cancer patients in China.
Journal: Frontiers in oncology
Published: February 16, 2025
iPSC modification strategies to induce immune tolerance.
Journal: Life medicine
Published: January 13, 2025
Global burden of colon and rectal cancer and attributable risk factors in 204 countries and territories from 1990 to 2021.
Journal: BMC gastroenterology
Published: January 12, 2025
Immune checkpoint inhibitor-related myocarditis in patients with lung cancer.
Journal: BMC cancer
Published: December 16, 2024
Last Updated: 09/26/2026